📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
NATH BIOGENE INDIA LTD.NATHBIOGENOther Agricultural Products
Open
135
High
138.83
Low
133.2
Close
137.46
Volume
9931
Exchange
nse
Time
01-Apr-2026

Outlook

Score:

3

Rating:

RISKY

Candlestick Pattern

CandlepatternofNathBiogeneIndiais
None
EstimatedStoplossofNathBiogeneIndiais
133.2
NathBiogeneIndiahasa
Bullishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofNathBiogeneIndiais
Unpredictableℹ
.

Trend

NathBiogeneIndiaisin
Sideways trendℹ
.
PriceofNathBiogeneIndiais
Downℹ
by

4.22

%.
Target
Buy@

132.97

Sell@

159.13

Current@

137.46

Volume

ThetradevolumesofNathBiogeneIndiahavebecome
Deficientℹ
ThevolumetrendforNathBiogeneIndiais
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofNathBiogeneIndiais

Down

by

55.08

%

Valuation

ThecurrentmarketpriceofNathBiogeneIndiais
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth1026crandtotalassetsworth1026cr,thebalancesheetofNathBiogeneIndiais:
Balancedℹ
.
Cashflow
NathBiogeneIndiahas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 11cr

.Itis
Downℹ
by

71.79

%.
77.27% i.e. ₹ 17cr earned in operatingℹ
13.64% i.e. ₹ 3cr spent in investingℹ
9.09% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
NathBiogeneIndiahas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 39cr

.Itis
Upℹ
by

18.18

%.
68.52% i.e. ₹ 74cr earned in operatingℹ
25% i.e. ₹ 27cr spent in investingℹ
6.48% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Income
TheincomeofNathBiogeneIndiais

₹ 45cr

and

Profit

is:

₹ 4cr

NathBiogeneIndiaProfitisdownby:

89.19

%andIncomeisDownby:

84.21

%
TheincomeofNathBiogeneIndiais

₹ 285cr

and

Profit

is:

₹ 37cr

NathBiogeneIndiaProfitisupby:

3600

%andIncomeisUpby:

418.18

%
TheincomeofNathBiogeneIndiais

₹ 55cr

and

Profit

is:

₹ 1cr

NathBiogeneIndiaProfitisdownby:

50

%andIncomeisUpby:

48.65

%
By using this site you agree to the use of cookies to deliver a better site experience.